These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21072305)

  • 1. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.
    Pachman DR; Jones JM; Loprinzi CL
    Int J Womens Health; 2010 Aug; 2():123-35. PubMed ID: 21072305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot flashes: a review of pathophysiology and treatment modalities.
    Morrow PK; Mattair DN; Hortobagyi GN
    Oncologist; 2011; 16(11):1658-64. PubMed ID: 22042786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone Therapy and Other Treatments for Symptoms of Menopause.
    Hill DA; Crider M; Hill SR
    Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
    Bordeleau L; Pritchard K; Goodwin P; Loprinzi C
    Clin Ther; 2007 Feb; 29(2):230-41. PubMed ID: 17472816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society.
    Menopause; 2015 Nov; 22(11):1155-72; quiz 1173-4. PubMed ID: 26382310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Estrogen: Treatment Options for Hot Flashes.
    McGarry K; Geary M; Gopinath V
    Clin Ther; 2018 Oct; 40(10):1778-1786. PubMed ID: 30217591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms and treatment in cancer therapy-induced early menopause.
    Boekhout AH; Beijnen JH; Schellens JH
    Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of menopause associated vasomotor symptoms and options available in its management.
    Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
    Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2023 nonhormone therapy position statement of The North American Menopause Society.
    “The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel
    Menopause; 2023 Jun; 30(6):573-590. PubMed ID: 37252752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot flashes: aetiology and management.
    Barton D; Loprinzi C; Wahner-Roedler D
    Drugs Aging; 2001; 18(8):597-606. PubMed ID: 11587246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors.
    Tran S; Hickey M; Saunders C; Ramage L; Cohen PA
    Support Care Cancer; 2021 Mar; 29(3):1183-1193. PubMed ID: 32940768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].
    Palácová M
    Klin Onkol; 2016; 29 Suppl 3():S29-38. PubMed ID: 28118722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women.
    Moyad MA
    Urology; 2002 Apr; 59(4 Suppl 1):20-33. PubMed ID: 11937433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
    Stearns V
    Treat Endocrinol; 2006; 5(2):83-7. PubMed ID: 16542048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
    Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
    Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally active nonhormonal hot flash therapies.
    Loprinzi CL; Stearns V; Barton D
    Am J Med; 2005 Dec; 118 Suppl 12B():118-23. PubMed ID: 16414336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stellate ganglion block as a treatment for vasomotor symptoms: Clinical application.
    Lee YS; Wie C; Pew S; Kling JM
    Cleve Clin J Med; 2022 Mar; 89(3):147-153. PubMed ID: 35232827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials.
    Kronenberg F; Fugh-Berman A
    Ann Intern Med; 2002 Nov; 137(10):805-13. PubMed ID: 12435217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot flashes revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us?
    Haimov-Kochman R; Hochner-Celnikier D
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):972-9. PubMed ID: 16167914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.